Clinical Trials Browser

Unknown × Uterine Cervical Neoplasms × Bevacizumab × Clear all

NCT05247619 2022-07-15

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT05444374 2022-07-05

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04974944 2021-10-01

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04973904 2021-07-22

Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT03912415 2020-09-18

FERMATA

Phase 3 Unknown

Uterine Cervical Neoplasms

NCT03912402 2019-05-09

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

Phase 2 Unknown

Uterine Cervical Neoplasms